Opill, the first non-prescription contraceptive, will take time to arrive in Puerto Rico

Opill, the first non-prescription contraceptive, will take time to arrive in Puerto Rico

A little over a week after the federal approval of Opill, the first contraceptive pill to be sold without a prescription, its demand has already begun to surface, although leaders of the pharmaceutical industry anticipated that its distribution on the island would start, at the earliest, at the end of the year.

“Patients have already asked us about the product, although it is too early to know their demand”said Idalia Bonilla, president of the College of Pharmacists of Puerto Rico.

The federal Food and Drug Administration (FDA) gave its approval to the drug on July 13, but its manufacturer, Perrigo Co., has already announced that it will not be available for sale until early 2024.

“As there is more information (about the pill), people are going to ask more, but those products take a while to arrive.”, commented, for her part, Linda Ayala, executive director of the Association of Community Pharmacies of Puerto Rico.

Opill will be marketed without age restriction and without the need for a prescription or medical prescription, being the first oral contraceptive in the United States to obtain authorization to be sold and dispatched in this way.

“We plan to distribute this product when it is available,” said the Cardinal Health company through Hector Otero, its spokesman on the island.

Cardinal Health is one of the distributors of pharmaceutical products in Puerto Rico.

Although they still do not know the exact date of Opill’s availability for sale, Otero indicated that Cardinal Health projects that it could be at the end of this year, that is, a little earlier than estimated by the manufacturer.

While, One of the questions that has arisen is what the price of the drug will beas insurance companies usually require a prescription to cover the drugs that are covered.

“Medical plans do not cover OTC drugs (‘over the counter’ or without a prescription), only (Medicare) Advantage plans,” Bonilla said.

According to the pharmacist, the average monthly cost of birth control pills in its bioequivalent modality is about $30. Name-brand ones, however, start at $150, he noted.

“There are few medical plan coverages that currently cover contraceptives, unless the diagnosis is for bleeding,” added Bonilla, who pointed out that the greatest availability of contraceptives is bioequivalent, not branded.

For now, the manufacturer Perrigo Co. has reported its intention to make Opill “broadly accessible and affordable”.

According to the FDA, Opill contains the hormone norgestrel and belongs to the class of drugs known as progestogens. This particular pill does not contain estrogen.

Norgestrel had been approved in the United States in 1973 for prescription use to prevent pregnancy. However, it had not been available since 2005 by decision of the then manufacturer (Pfizer), which stopped selling its Ovrette pill for “commercial reasons”.

The FDA reported that in clinical trials, Opill was shown to be 98% effective in women who took it, without fail, every day at the same time.. Irregular vaginal bleeding, nausea, breast tenderness, and headaches are some of the more common side effects seen with the drug, although they are generally mild.

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!